Comparing the effect and safety of bowel preparation for colonoscopy with Macrogol 4000 Powder (Changsong) and Polyethylene Glycol Electrolytes Powder (Heshuang)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024489

Enrollment

Unknown

Registered

2019-07-13

Start date

2019-07-12

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Intestinal preparation

Interventions

Group A (Heshuang):Polyethylene Glycol Electrolytes Powder (Heshuang)

Group B(Changsong):Macrogol 4000 Powder (Changsong)

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients aged 18 to 75 years who underwent colonoscopy at the First Affiliated Hospital of Chongqing Medical University signed a colonoscopy consent form and informed consent for the study.

Exclusion criteria

Exclusion criteria: 1) Gastrointestinal obstruction or perforation; 2) Severe acute intestinal infection; 3)Toxic megacolon; 4) Consciousness disorder; 5) Allergy to the drug ingredients; 6)Inability to swallow autonomously (nasogastric tube may be useful in this case); 7)Ileostomy; 8)Pregnancy; 9) Peritonitis; 10) Taking other laxatives within one week before examination; 11) Severe heart, lung, liver, kidney or metabolic diseases and electrolyte disorders; 12) Currently participating in other clinical studies.

Design outcomes

Primary

Measure	Time frame
The Boston bowel preparation scale;	—

Secondary

Measure	Time frame
Adverse Effects Rate;Adverse Effects Rate;	—

Countries

China

Contacts

Public ContactXuchun Zhou

The First Affiliated Hospital of Chongqing Medical University

chqxchzh@163.com+86 13883023222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026